In addition, unlike other tumor suppressors which are frequently acquire loss of-function mutations, the highly stabilized mutant p53 proteins may confer unique gain-of-function (GOF) capability to actively promote tumorigenic events [9, 10], including enhanced tumor growth, invasion, metastasis and resistance to therapeutic drugs. The gene discussed is TP53; the disease is neoplasm.